May 29, 2007 — Abbott announced positive results last week from ABSORB, the world’s first clinical trial evaluating the ...
May 29, 2007 — Doctors at University of Pittsburgh Medical School, (UPMC) have begun a study using an investigational ...
May 29, 2007 — Abbott announced Friday, May 25, that it has initiated a voluntary, nationwide recall of its ARCHITECT ...
Behavioral science is being applied in unique ways for enterprise imaging product design. Involving clinicians in the ...
May 29, 2007 — Boston Scientific Corp. has received CE Mark for its TAXUS Liberte Long paclitaxel-eluting coronary stent ...
May 29, 2007 — The FDA has cleared the Mynx VCS vascular closure system (VCD) by AccessClosure designed to seal a ...
May 29, 2007 — Orqis Medical Corp., a clinical-stage company developing devices for the treatment of congestive heart ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 23, 2007 — MedicalCV Inc. has announced that the United States Patent and Trademark Office ("USPTO") has issued ...
May 23, 2007 — XTENT Inc. announced positive six-month follow-up data from the CUSTOM II clinical trial, which assessed ...
May 23, 2007 — InspireMD has announced this week the enrollment of 19 patients in its First in Man study in a ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
May 22, 2007 — Luna Innovations has announced it has received a market clearance letter in response to its 510(k) ...
May 23, 2007 — MicroMed Cardiovascular Inc. has announced that on Monday, May 14, 2007, doctors at Freeman Hospital in ...
May 21, 2007 — OrbusNeich announced today it has received CE Mark approval for three interventional cardiology products ...
Today, cloud-native analytics can automate data acquisition and synthesize complex data from multiple sources. Here, we ...
May 21, 2007 — Findings presented last week during the annual meeting of the Heart Rhythm Society in Denver indicate a common stress test, using GE Healthcare’s latest algorithm for the measurement of T-wave Alternans (TWA), can be useful in predicting sudden cardiac death, even in those without a previous heart attack or symptoms of heart failure.
May 21, 2007 — Sanofi-aventis has announced that the FDA has approved a supplemental New Drug Application (sNDA) for the ...
May 18, 2007 — Medicure, a biopharmaceutical company focused on the research, development and commercialization of novel ...